High Court Rejects Apotex Fraud Case Against Merck

Law360, New York (June 3, 2008, 12:00 AM EDT) -- The U.S. Supreme Court has refused to review a lower court's rejection of Apotex Corp.’s fraud claims against Merck & Co. Inc. in the companies' long-running patent dispute over a blood pressure drug.

The Supreme Court's order on Monday denying certiorari in the case said that Chief Justice John Roberts was not involved in the decision.

An attorney for Apotex could not immediately be reached, and an attorney for Merck declined to comment.

Apotex had petitioned the Supreme Court after the U.S. Court of Appeals for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.